Invention Grant
- Patent Title: 7,9-substituted tetracycline compounds
- Patent Title (中): 7,9-取代四环素化合物
-
Application No.: US10738862Application Date: 2003-12-16
-
Publication No.: US07696186B2Publication Date: 2010-04-13
- Inventor: Mark L. Nelson , Roger Frechette , Peter Viski , Mohamed Y. Ismail , Todd Bowser , Laura McIntyre , Beena Bhatia , Paul Hawkins , Laxma Reddy , Karen Stapleton , Tadeusz Warchol , Paul Sheahan
- Applicant: Mark L. Nelson , Roger Frechette , Peter Viski , Mohamed Y. Ismail , Todd Bowser , Laura McIntyre , Beena Bhatia , Paul Hawkins , Laxma Reddy , Karen Stapleton , Tadeusz Warchol , Paul Sheahan
- Applicant Address: US MA Boston
- Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee: Paratek Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Heidi A. Erlacher
- Main IPC: A61K31/65
- IPC: A61K31/65 ; C07C237/28
Abstract:
The present invention pertains to novel 7,9-substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for minocycline and tetracycline compounds in general, such as blocking tetracycline efflux and modulation of gene expression.
Public/Granted literature
- US20040138183A1 7,9-substituted tetracycline compounds Public/Granted day:2004-07-15
Information query
